2014;10(1 Suppl):S7683
BrightFocus Alzheimers Disease Research program has funded research into brain metabolism, inflammation, and novel therapeutic approaches that helped lay the groundwork for innovative discoveries like GLP-1s in Alzheimers disease
The trade-off is that slower escalation means slower weight loss initially, but the improved tolerability often leads to better long-term adherence and outcomes
1, Table 2 and Supplementary Section 5) seems more likely, while any effect on psychotic, mood and anxiety disorders appears less consistent and in need of further investigation
Led by Robert Kennedy Jr., the initiative has raised concerns among public health experts over potential disruptions to existing vaccine protocols
The study reported a significant improvement in the resolution of MASH, with 39% of patients achieving this outcome as compared to 9% in the placebo group